In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva Pharmaceutical Industries Ltd.

www.tevapharm.com

Latest From Teva Pharmaceutical Industries Ltd.

Who's Hired? Teva And Lupin Shake Up Supply Chain

Teva has announced a leadership change in its global operations, while Lupin has made a key appointment to focus on quality and compliance. Among other changes in leadership roles, Olainfarm has seen one of its six management board members resign. 

Appointments Strategy

US Supreme Court Refuses ‘Blocking-Patent’ Review

Acorda has been denied its request for the US Supreme Court to review a ruling that revolved around the ‘blocking-patent’ doctrine, which has led to invalidity rulings on patents protecting several major brands.

Intellectual Property Generic Drugs

Apotex Suffers Adverse Tarceva Reversal

Apotex has seen last years decision that a patent protecting the Tarceva erlotinib oncology brand until 2021 was obvious overturned by a US Court of Appeals.

Intellectual Property Cancer

AstraZeneca Gains US OK For Fasenra In Patient-Friendly Form

The company is keeping up the pressure on GSK, getting approval for self-administration for Fasenra a few months after a similar green light for severe asthma rival Nucala.

Respiratory Approvals
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register